Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01562106 · ClinicalTrials.gov registry record · NA
Investigating the Use of Fluorescence Imaging in Endometrial Cancer Surgery
A NA study, sponsored by Swedish Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 123
- Enrollment target
NCT01562106 is a NA study that has completed, run by Swedish Medical Center. The registered enrollment target is 123 participants.
The verdict
NCT01562106, a NA study, has completed, sponsored by Swedish Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 123 participants
- Enrollment target
Study Summary
The main purpose of the study is to evaluate the detection rate and accuracy of fluorescence imaging in endometrial cancer staging by sentinel node assessment.
Interventions
- PROCEDURE Fluorescence-guided sentinel lymph node detection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2012-02 |
| Est. Completion | 2016-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01562106
The ClinicalTrials.gov registry entry for NCT01562106 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Swedish Medical Center, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fluorescence-guided sentinel lymph node detection is the first listed.
NCT01562106 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01562106 about?
NCT01562106 is a clinical study titled "Investigating the Use of Fluorescence Imaging in Endometrial Cancer Surgery". The main purpose of the study is to evaluate the detection rate and accuracy of fluorescence imaging in endometrial cancer staging by sentinel node assessment.
What is the current status of trial NCT01562106?
This trial is currently completed. It is a NA study. The enrollment target is 123 participants. The study started on 2012-02. Estimated completion is 2016-08.
What interventions are being tested in trial NCT01562106?
The interventions under investigation include: Fluorescence-guided sentinel lymph node detection (PROCEDURE).
Who is sponsoring clinical trial NCT01562106?
This trial is sponsored by Swedish Medical Center, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.